FDA Inspection 1166032 — Department Of Defense - Air Force

Department Of Defense - Air Force — FEI 1577551

The FDA completed an inspection of Department Of Defense - Air Force on Mar 30, 2022 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 30, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dayton, OH (United States)

Citations

IDCFRDescription
1809321 CFR 630.10(g)(1)Proof Of Identity

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.